May Hamza

1.2k total citations
30 papers, 939 citations indexed

About

May Hamza is a scholar working on Physiology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, May Hamza has authored 30 papers receiving a total of 939 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Physiology, 13 papers in Pharmacology and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in May Hamza's work include Pain Mechanisms and Treatments (16 papers), Botulinum Toxin and Related Neurological Disorders (9 papers) and Inflammatory mediators and NSAID effects (7 papers). May Hamza is often cited by papers focused on Pain Mechanisms and Treatments (16 papers), Botulinum Toxin and Related Neurological Disorders (9 papers) and Inflammatory mediators and NSAID effects (7 papers). May Hamza collaborates with scholars based in Egypt, United States and Germany. May Hamza's co-authors include Raymond A. Dionne, Kay Brune, Hans Gühring, Mehmet Ateş, Tianxia Wu, Catherine Ledent, William F. Craig, Akshay S. Vakharia, Paul F. White and Carl Noe and has published in prestigious journals such as Journal of Clinical Investigation, Diabetes Care and Pain.

In The Last Decade

May Hamza

30 papers receiving 904 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
May Hamza Egypt 16 427 366 243 167 92 30 939
Laurence Daulhac France 19 488 1.1× 184 0.5× 270 1.1× 299 1.8× 185 2.0× 25 1.0k
Hanna Viisanen Finland 16 524 1.2× 171 0.5× 247 1.0× 96 0.6× 33 0.4× 25 799
Steve Bramwell United Kingdom 8 434 1.0× 214 0.6× 338 1.4× 304 1.8× 61 0.7× 9 891
Amanda Ellis United States 10 621 1.5× 122 0.3× 331 1.4× 237 1.4× 79 0.9× 16 1.1k
Stephen Butler Sweden 12 396 0.9× 159 0.4× 221 0.9× 107 0.6× 221 2.4× 25 810
Joshua W. Little United States 15 616 1.4× 146 0.4× 264 1.1× 407 2.4× 92 1.0× 27 1.3k
Megumi Matsuda Japan 17 517 1.2× 116 0.3× 228 0.9× 222 1.3× 152 1.7× 28 1.1k
Katherine Walker United Kingdom 12 707 1.7× 119 0.3× 483 2.0× 323 1.9× 125 1.4× 17 1.2k
Song Cao China 18 297 0.7× 120 0.3× 160 0.7× 230 1.4× 69 0.8× 65 931

Countries citing papers authored by May Hamza

Since Specialization
Citations

This map shows the geographic impact of May Hamza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by May Hamza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites May Hamza more than expected).

Fields of papers citing papers by May Hamza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by May Hamza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by May Hamza. The network helps show where May Hamza may publish in the future.

Co-authorship network of co-authors of May Hamza

This figure shows the co-authorship network connecting the top 25 collaborators of May Hamza. A scholar is included among the top collaborators of May Hamza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with May Hamza. May Hamza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hasanin, Amany Helmy, et al.. (2024). A neuroprotective effect of pentoxifylline in rats with diabetic neuropathy: Mitigation of inflammatory and vascular alterations. International Immunopharmacology. 128. 111533–111533. 6 indexed citations
3.
El‐Bakly, Wesam M., et al.. (2016). Prophylactic L-arginine and ibuprofen delay the development of tactile allodynia and suppress spinal miR-155 in a rat model of diabetic neuropathy. Translational research. 177. 85–97.e1. 24 indexed citations
4.
Hamza, May, et al.. (2015). Nitric oxide is involved in ibuprofen preemptive analgesic effect in the plantar incisional model of postsurgical pain in mice. Neuroscience Letters. 614. 33–38. 17 indexed citations
5.
Saleh, Lobna A., et al.. (2014). Ibuprofen suppresses depressive like behavior induced by BCG inoculation in mice: role of nitric oxide and prostaglandin. Pharmacology Biochemistry and Behavior. 125. 29–39. 27 indexed citations
6.
Hamza, May, Xiaomin Wang, Albert Adam, et al.. (2010). Kinin B1 Receptors Contributes to Acute Pain following Minor Surgery in Humans. Molecular Pain. 6. 12–12. 22 indexed citations
7.
Hamza, May, et al.. (2009). Upregulation of IL-6, IL-8 and CCL2 gene expression after acute inflammation: Correlation to clinical pain. Pain. 142(3). 275–283. 108 indexed citations
8.
Hamza, May & Raymond A. Dionne. (2009). 2020 foresight: Envisioning therapeutic innovations for pain. Drug Discovery Today Therapeutic Strategies. 6(3). 113–119. 1 indexed citations
9.
Hamza, May & Raymond A. Dionne. (2009). Mechanisms of Non-Opioid Analgesics Beyond Cyclooxygenase Enzyme Inhibition. Current Molecular Pharmacology. 2(1). 1–14. 7 indexed citations
10.
Wang, Xiaomin, et al.. (2008). COX Inhibitors Downregulate PDE4D Expression in a Clinical Model of Inflammatory Pain. Clinical Pharmacology & Therapeutics. 84(1). 39–42. 8 indexed citations
11.
Gordon, Sharon M., et al.. (2008). The Differential Effects of Bupivacaine and Lidocaine on Prostaglandin E2 Release, Cyclooxygenase Gene Expression and Pain in a Clinical Pain Model. Anesthesia & Analgesia. 106(1). 321–327. 44 indexed citations
12.
Wang, Xiaomin, Tianxia Wu, May Hamza, et al.. (2006). Rofecoxib modulates multiple gene expression pathways in a clinical model of acute inflammatory pain. Pain. 128(1). 136–147. 31 indexed citations
13.
Reinold, H.-M., Seifollah Ahmadi, Cornelia Heindl, et al.. (2005). Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype. Journal of Clinical Investigation. 115(3). 673–679. 158 indexed citations
14.
Ateş, Mehmet, et al.. (2003). Intrathecally applied flurbiprofen produces an endocannabinoid‐dependent antinociception in the rat formalin test. European Journal of Neuroscience. 17(3). 597–604. 65 indexed citations
15.
Seidel, Kay, May Hamza, Mehmet Ateş, & Hans Gühring. (2003). Flurbiprofen inhibits capsaicin induced calcitonin gene related peptide release from rat spinal cord via an endocannabinoid dependent mechanism. Neuroscience Letters. 338(2). 99–102. 23 indexed citations
16.
Gühring, Hans, May Hamza, Marina Sergejeva, et al.. (2002). A role for endocannabinoids in indomethacin-induced spinal antinociception. European Journal of Pharmacology. 454(2-3). 153–163. 108 indexed citations
17.
Gühring, Hans, et al.. (2001). HU-210 shows higher efficacy and potency than morphine after intrathecal administration in the mouse formalin test. European Journal of Pharmacology. 429(1-3). 127–134. 27 indexed citations
18.
Hamza, May, Paul F. White, William F. Craig, et al.. (2000). Percutaneous electrical nerve stimulation: a novel analgesic therapy for diabetic neuropathic pain.. Diabetes Care. 23(3). 365–370. 156 indexed citations
19.
Ghoname, E.A., et al.. (1999). PERCUTANEOUS ELECTRICAL NERVE STIMULATION (PENS). Anesthesia & Analgesia. 88(2S). 209S–209S. 4 indexed citations
20.
Ghoname, E.A., William F. Craig, Paul F. White, et al.. (1998). PERCUTANEOUS ELECTRICAL NERVE STIMULATION (PENS). Anesthesiology. 89(Supplement). 1100A–1100A. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026